*Actual vial appearance, contents, and dosage may vary and is based on your prescription.

Cedar

This hair loss support program combines biotin, finasteride, and minoxidil—three well-studied compounds commonly used in clinical hair-loss care—to support hair follicle health, scalp environment, and hair retention pathways. Finasteride and minoxidil have been extensively studied for androgen-related hair loss, while biotin is included to support keratin production and overall hair structure. When prescribed together in a provider-directed formulation, this combination is designed to address multiple mechanisms involved in hair thinning and pattern hair loss.

Free Shipping

Medical Consultation Included

$ 200 Per Month

$ 600 Full Price

Start Your Plan

Provider-selected compounded hair loss formulation
Available in 48 states (excluding Alabama and Mississippi)
No hidden membership, consultation, or shipping costs
Care reviewed by a licensed provider in your state
Prescription issued only when clinically appropriate

Educational only; outcomes are not guaranteed.

Finasteride – DHT Modulation Pathway

Finasteride is a 5-alpha-reductase inhibitor that has been studied for its role in reducing dihydrotestosterone (DHT), a hormone associated with androgen-related hair follicle miniaturization.
https://pubmed.ncbi.nlm.nih.gov/9777765/

Minoxidil – Follicular & Scalp Circulation Pathways

Minoxidil has been studied for its role in supporting hair follicle activity and prolonging the anagen (growth) phase of the hair cycle through local scalp mechanisms.
https://pubmed.ncbi.nlm.nih.gov/3549806/

Biotin – Hair Structure & Keratin Support

Biotin (vitamin B7) is involved in keratin infrastructure and is commonly included to support hair strength and integrity, particularly in individuals with low biotin status.
https://pubmed.ncbi.nlm.nih.gov/24315963/

Initial 3-month care period
Designed to support consistency, monitoring, and continuity of care
Ongoing care options available following the initial period, with the ability to manage or discontinue thereafter

Clinical review typically completed within 24 hours
Pharmacy processing may take 2–7 business days, depending on formulation
Once dispensed, medication is shipped via 2-day delivery

Supports hair retention and follicle signaling pathways
Addresses androgen-related hair thinning mechanisms
Supports scalp environment and follicular health
Designed for long-term, consistency-based care under provider supervision

Prescriptions are issued by licensed healthcare providers based on an individual clinical evaluation and medical eligibility. Compounded hair-loss formulations are not FDA-approved, and their safety and effectiveness have not been independently evaluated by the FDA.

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.

Important Note:

Information provided is for educational purposes only and does not constitute medical advice. All care and prescriptions are provided solely at the discretion of a licensed healthcare provider following an individual evaluation.

Finasteride and Male Pattern Hair Loss (NEJM)

Minoxidil and Hair Growth Mechanisms

Long-Term Finasteride Hair Retention Study

Biotin and Hair/Nail Health Review

Androgenetic Alopecia Pathophysiology Review

GLP 1 + B12

I appreciated how everything was explained clearly, step by step, from the very beginning. The process never felt rushed or confusing, and there was no pressure at any point. Instead, the guidance helped me understand my options and feel comfortable moving forward at my own pace.

A Celara Med User

GLP 1 + B12

A Celara Med User

Your provider will determine the appropriate topical, oral, or combination approach based on your evaluation and medical history.

Adults experiencing androgen-related hair thinning or pattern hair loss may be evaluated by a licensed healthcare provider.

Hair growth cycles take time. Many individuals notice gradual changes over several months with consistent use. Results vary.

Side effects vary by component and formulation and may include scalp irritation (topicals) or systemic effects (oral therapies). These are reviewed during provider evaluation.

In some cases, providers may approve combination use with additional hair or wellness therapies, depending on individual needs.

This hair loss program through Celara Med is available in 48 states, excluding Alabama and Mississippi, subject to state regulations and provider licensure.

Yes. Hair loss support is offered within a structured care plan designed for continuity, monitoring, and appropriate clinical oversight.